Adamas Pharma Stock Price (NASDAQ:ADMS)

Add to My Stocks
$25.21 $0.29 (1.14%) ADMS stock closing price Jun 22, 2018 (Closing)
Prev Close* : $25.5
Market Cap:
Day Low: $24.61
52 Week Low: $13.50
Open: $25.63
Volume: -
Day High: $25.7
52 Week High: $44.00

Latest Stock Market News

Latest Articles

Adamas Pharma News - From Partners

ADMS Stockcharts

View ADMS PE ratio, PS ratio stocks charts and compare with peers.
ADMS Chart
Note: Compare Adamas Pharma stock price history with the index and industry peers.

Adamas Pharma Valuation

PE ratio
(price earnings ratio)
PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Adamas Pharma Returns

(return on equity)

Adamas Pharma Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield

ADMS Industry Peers

Company Price Change (%)
Amphastar Pharma (AMPH)15.770.33 (2.05%)
Cymabay (CBAY)13.740.11 (0.79%)
Acadia Pharma (ACAD)16.330.38 (2.38%)
Merck (MRK)61.470.29 (0.47%)
Glaxosmithkline (GSK)40.890.08 (0.2%)
Depomed (DEPO)7.320.08 (1.1%)
H. Lundbeck (HLUYY)73.590.21 (0.29%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Aquinox Pharma (AQXP)15.510.79 (5.37%)
Teligent (TLGT)3.880.09 (2.37%)
Akorn (AKRX)16.030.27 (1.71%)
Corium (CORI)8.90.07 (0.79%)
Allergan (AGN)173.420.93 (0.54%)
Progenics Pharma (PGNX)8.490.02 (0.24%)
Top gainers from Medical-Generic Drugs industry
* As of Jun 22, 2018
CompanyPriceChange (%)
Supernus Pharma (SUPN)57.051.3 (2.23%)
Adamas Pharma (ADMS)25.210.29 (1.14%)
Mallinckrodt (MNK)19.270.17 (0.87%)
Mylan (MYL)38.310.32 (0.83%)
AxoGen (AXGN)51.350.4 (0.77%)
Dr. Reddy's Laboratories (RDY)34.070.18 (0.53%)
Teva Pharmaceutical (TEVA)23.990.02 (0.08%)
Top losers from Medical-Generic Drugs industry
* As of Jun 22, 2018

Adamas Pharmaceuticals Inc Stock News - Partner Headlines

Adamas Pharma Financial Statements

income statement20172016201520142013
Net Sales or Revenues--1.91M55.84M71.09M
Net Income-89.49M-60.05M-51.8M10.22M50.92M
Total Operating Expense88.47M61.55M59.34M37.33M14.07M
View Adamas Pharma income statement
balance sheet20172016201520142013
Total Assets186.17M142.47M128.74M161.18M86.21M
Total Liabilities120.05M10.29M12.55M14.11M10.46M
Shareholders Equity66.12M132.18M116.18M147.07M75.75M
View Adamas Pharma balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities3.29M--6.67M10.47M-29.4M
Net Cash from (used by) Operating Activities-66.82M-48.06M-47.21M26.19M26.8M
Increase (Decrease) in Prop Plant And Equipment-1.25M-1.62M-1.39M-1.28M-0.16M
View Adamas Pharma cash flow statement

Adamas Pharma Stock Message Board

An investor needs to spend $25.21 to buy ADMS stock, as the closing Adamas Pharma stock price is $25.21. Stock price or share price can be used to find the total market value of a company. Adamas Pharma market cap stands at $688.05M as of Jun 22, 2018. Adamas Pharma valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

For recognizing and analyzing the real performance of Adamas Pharma stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. The volume of shares traded stood at 1,100,159 on the last trading day, as is evident from Adamas Pharma stock chart, and ADMS stock quote data. A dividend is a cash payment made from a company's earnings and is distributed among shareholders. Adamas Pharma does not pay dividends. Adamas Pharma stock price history, gives the entire historical data for ADMS stock.